2018
DOI: 10.1016/j.bpj.2017.11.1990
|View full text |Cite
|
Sign up to set email alerts
|

Microscopy Using Fluorescent Drug Biosensors for “Inside-Out Pharmacology”

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
1
1

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…In parallel with development of iAChSnFR, we also mutated OpuBC to recognize nicotine or the smoking-cessation drug varenicline 36 (PDB 6EFR). Further experiments produced variants that detect other neural drugs, including the rapidly acting antidepressant S-ketamine 87 , selective serotonin reuptake inhibitor antidepressants, and opioids 88 . In the original OpuBC and related PBPs 89 , and in the better characterized sensors, ligand binding is mediated by cation-π interactions between the protonated secondary, protonated tertiary, or quaternary amine of the ligand and aromatic residues.…”
Section: Discussionmentioning
confidence: 99%
“…In parallel with development of iAChSnFR, we also mutated OpuBC to recognize nicotine or the smoking-cessation drug varenicline 36 (PDB 6EFR). Further experiments produced variants that detect other neural drugs, including the rapidly acting antidepressant S-ketamine 87 , selective serotonin reuptake inhibitor antidepressants, and opioids 88 . In the original OpuBC and related PBPs 89 , and in the better characterized sensors, ligand binding is mediated by cation-π interactions between the protonated secondary, protonated tertiary, or quaternary amine of the ligand and aromatic residues.…”
Section: Discussionmentioning
confidence: 99%
“…Other neuronal drugs may also operate via inside-out pathways (Jong et al, 2009; Lester et al, 2012, 2015). With further modifications to the ligand site, preliminary data show that it may be possible to develop families of biosensors for optical subcellular pharmacokinetics of several amine-containing drug classes (Muthusamy et al, 2018; Shivange et al, 2017. Annual Meeting of the Society of General Physiologists.…”
Section: Discussionmentioning
confidence: 99%